Sentences with phrase «for schizophrenia treatment»

These findings have provided a new target for schizophrenia treatment.

Not exact matches

ALKS 3831 is a treatment for schizophrenia that avoids the side effects of weight gain and metabolic problems that the incumbent drug has, and a phase 3 trial for it should read out in the fall of 2018.
In addition to the new work's potential for RS, there is speculation that it could pave the way to treatments for other neurological disorders, such as learning disabilities, schizophrenia, autism and newborn encephalopathy as well as some mental retardation that has also been linked to the Mecp2 gene.
They are hopeful that this discovery may hold secrets to designing better treatments for schizophrenia, bipolar disorder, and other mental illnesses.
Parsing these complex symptoms could help inform new treatment approaches for schizophrenia and other disorders.
«Innovative genetic, cellular techniques help identify multiple disease targets: CRISPR - Cas9 and iPSC advances hold treatment promise for schizophrenia, addiction, Zika infection and other diseases.»
Neurofeedback is a technique used for the treatment of clinical disorders (like depression, anxiety, chronic pain, ADHD and schizophrenia etc.) and enhancement of brain performance.
The ability to shut out stimuli could also turn nicotine into a treatment for schizophrenia, where afflicted individuals are overwhelmed by sights, sounds and thoughts that most of us would either ignore or quickly dismiss.
Advances in our understanding of the biological pathways and mechanisms involved will help uncover new targets for treatment, which could one day translate into better, more personalised care for people living with schizophrenia
Non-Hispanic blacks are almost twice as likely as non-Hispanic whites to be diagnosed with schizophrenia, but they're significantly less likely to receive medication for treatment, according to researchers.
Professor Sir Mike Owen, who leads the MRC Centre at Cardiff University, said: «These findings are another important step on the long road to new treatments for schizophrenia and will be crucial for identifying potential new drugs, which will become an increasing focus of our work in the coming years.»
Understanding the function of this gene — described this month in journal Molecular Psychiatry — could lead to more effective treatments for schizophrenia.
If the findings can be replicated in larger studies, it might be possible for doctors to identify which people will later develop schizophrenia, and offer them preventative treatments, he says.
But a drug that blocks the rush of noradrenaline through your body can boost your confidence, and may also lead to new treatments for schizophrenia and obsessive compulsive disorder.
For example, a participant with schizophrenia may have mild depressive symptoms that are not accounted for in the treatment plFor example, a participant with schizophrenia may have mild depressive symptoms that are not accounted for in the treatment plfor in the treatment plan.
Future studies about romantic attachment will focus on using the findings from research such as Young's and Diamond's to develop new treatments for grief associated with partner separation or loss and for disorders that involve social deficits, such as schizophrenia and autism.
Christianson said the findings set the stage for a large - scale investigation of the brain circuits that work together to orchestrate responses to social emotional information with the hope that such research will lead to better treatment for people with conditions marked by aberrant social cognition, such as autism or schizophrenia.
Lately, the drug has also been in the news as a possible treatment for schizophrenia, after psychotic symptoms disappeared in a young Japanese man treated with the antibiotic for pneumonia.
«Childhood trauma link offers treatment hope for people with schizophrenia: People with schizophrenia may now benefit from more effective, tailored treatments and greater self - empowerment, thanks to research establishing a link between childhood trauma and some of schizophrenia's most common symptoms..»
Stoll's findings have yet to be replicated, but other researchers have since studied omega - 3s as a treatment for depression, schizophrenia, borderline personality disorder, and attention deficit hyperactivity disorder, or ADHD.
The discovery may pave the way for new treatments for autism and schizophrenia.
Fish oil supplements have been investigated as a treatment for adults with schizophrenia, but so far results have been mixed — four trials found no benefit while another four found a small reduction in symptoms.
Although exercise has been shown to be an effective treatment for people with long - term schizophrenia, no studies have assessed its effects on psychiatric symptoms in young adults with early psychosis, until now.
Unlike most treatments for schizophrenia — such as medication to subdue delusions — this program was designed to address the condition's «negative» traits, those that most resemble autism.
But Perron is emphatic: Although the research looks promising, especially for use in MS, a lot still needs to be done until we can see this as a general treatment for schizophrenia or MS.
However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options.»
«New schizophrenia treatments may be effective for subgroup of patients.»
«Repairing the brain: Two genes unlock potential for treatment of schizophrenia
The discovery of specialist stem cells responsible for our most advanced cognition could pave the way for new treatments for autism and schizophrenia
Antipsychotic medications, a mainstay of treatment for schizophrenia, alleviated some of the animals» symptoms.
Published May 4, 2015, in Nature Neuroscience, the new findings may eventually lead to treatment strategies targeted for the underlying causes of schizophrenia and related disorders, said the study's corresponding author Scott Soderling, an associate professor of cell biology and neurobiology in the Duke School of Medicine.
It's possible that one day, a new treatment for schizophrenia could be developed based on these findings that would target an underlying cause of the disease, instead of just the symptoms, as current treatments do, the researchers said.
It also presents possibilities for potential treatments for schizophrenia designed around enhancing BDNF levels.
Hallucinations occur when this internal fact - checking fails, a finding that could point toward better treatments for schizophrenia and other psychiatric disorders.
«Drug treatments for schizophrenia have barely changed over the past few decades, as they still target dopamine receptors,» says study co-author Dr Andrew McQuillin, head of the UCL Molecular Psychiatry team that first discovered GRM3.
The discovery could be turned into a treatment for conditions associated with abnormal neural circuitry, such as schizophrenia.
Researchers randomly selected 801 veterans undergoing treatment for schizophrenia at Veterans Health Administration medical centers in California, New York, Louisiana and Texas.
Now, by dampening the activity of a small group of neurons deep within the mouse brain, researchers have produced cognitive deficits similar to those found in those with schizophrenia, a discovery that they say could potentially lead to new treatments for the disorder, which affects roughly 24 million people worldwide.
In addition, she said, the data suggest new avenues of treatment for disorders that have social behavior deficits, from autism to schizophrenia or dementia.
With persistence — and some luck — the research could lead to better treatments or even, one day, a cure for schizophrenia and autism.
The discovery paves the way for new treatments and hints at the cause of more common hallucinations, such as those associated with schizophrenia.
For some time, doctors have believed that helping the immune system may benefit the treatment of schizophrenia, but until now there has been no conclusive evidence that this would be effective.
The FDA has approved antipsychotics for treatment of certain mental disorders, particularly schizophrenia and bipolar disorder, yet the majority of the people in the study had no such diagnosis.
«Advances on this subject bring new perspectives for the treatment and diagnosis of schizophrenia,» Rehen says.
The results could lead to meaningful new treatments not only for schizophrenia but also for bipolar disorder and multiple sclerosis.
Treatment would look very different for a person whose psychotic experiences were linked to depression or anxiety disorders or were the one - time result of acute stress, compared with a person who is showing the first signs of schizophrenia.
There are as yet no licensed pharmaceutical treatments to improve cognitive functions for people with schizophrenia.
Research into these variations could lead to sex - specific treatments for disorders such as depression and schizophrenia
Antipsychotic medications, a mainstay of treatment for schizophrenia, alleviated some of the animals» symptoms.In the new study, Soderling, postdoctoral researcher Il Hwan Kim, and their team characterized three brain abnormalities in the Arp2 / 3 mice that also appear in people with schizophrenia.
Treatments for schizophrenia have not advanced in more than 50 years, since the discovery of drugs that reduce the activity of the chemical messenger dopamine.
a b c d e f g h i j k l m n o p q r s t u v w x y z